Article de revue

Antibody levels and protection after hepatitis B vaccine: Results of a 30-year follow-up study and response to a booster dose

Michael G. Bruce, Dana Bruden, Debby Hurlburt, Carolyn Zanis, Gail Thompson, Lisa Rea, Michele Toomey, Lisa Townshend-Bulson, Karen Rudolph, Lisa Bulkow, Philip R. Spradling, Richard Baum, Thomas Hennessy, Brian J. McMahon

Based on anti-HBs level ≥10 mIU/mL at 30 years and an 88% booster dose response, the researchers estimate that ≥90% of participants had evidence of protection 30 years later. Booster doses are not needed.

Auteurs

Langues

  • Anglais

Année de publication

2016

Journal

J Infect Dis.

Type

Article de revue

Catégories

Maladies

Pays

Mots-clés

Régions de l'OMS

Log in to vote

Ajouté par: Moderator

Ajouté le: 2016-02-09 05:28:19

Consultations: 1143

Liens

Signaler un problème

Ajouter une ressource